+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Therapeutic BCG Vaccine Market by Type (Immune BCG, Therapy BCG), Demographics (Adults, Pediatrics), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4986049
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Therapeutic BCG Vaccine Market size was estimated at USD 57.76 million in 2023, USD 60.31 million in 2024, and is expected to grow at a CAGR of 4.50% to reach USD 78.63 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Therapeutic BCG Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Therapeutic BCG Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Therapeutic BCG Vaccine Market, highlighting leading vendors and their innovative profiles. These include AJ Vaccines A/S, Bharat Biotech Ltd., Biomed-Lublin S.A., China National Biotec Group Company Limited, Green Signal Bio Pharma Private Limited, InterVax Ltd., Japan BCG Laboratory, Merck & Co., Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Statens Serum Institut, Taj Pharmaceuticals Limited, and Torlak Institute of Virology.

Market Segmentation & Coverage

This research report categorizes the Therapeutic BCG Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Immune BCG
    • Therapy BCG
  • Demographics
    • Adults
    • Pediatrics
  • End User
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Therapeutic BCG Vaccine Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Therapeutic BCG Vaccine Market?
  3. What are the technology trends and regulatory frameworks in the Therapeutic BCG Vaccine Market?
  4. What is the market share of the leading vendors in the Therapeutic BCG Vaccine Market?
  5. Which modes and strategic moves are suitable for entering the Therapeutic BCG Vaccine Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Frequently Asked Questions about the Global Therapeutic BCG Vaccine Market

What is the estimated value of the Global Therapeutic BCG Vaccine Market?

The Global Therapeutic BCG Vaccine Market was estimated to be valued at $60.31 Million in 2024.

What is the growth rate of the Global Therapeutic BCG Vaccine Market?

The growth rate of the Global Therapeutic BCG Vaccine Market is 4.5%, with an estimated value of $78.63 Million by 2030.

What is the forecasted size of the Global Therapeutic BCG Vaccine Market?

The Global Therapeutic BCG Vaccine Market is estimated to be worth $78.63 Million by 2030.

Who are the key companies in the Global Therapeutic BCG Vaccine Market?

Key companies in the Global Therapeutic BCG Vaccine Market include AJ Vaccines A/S, Bharat Biotech Ltd., Biomed, Lublin S.A., China National Biotec Group Company Limited, Green Signal Bio Pharma Private Limited, InterVax Ltd., Japan BCG Laboratory, Merck & Co., Inc. and Sanofi S.A..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Therapeutic BCG Vaccine Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising infant population and growing advancement in the pediatric care
5.1.1.2. High investment in research & development of therapeutic BCG vaccine
5.1.1.3. Increasing awareness through vaccination campaign
5.1.2. Restraints
5.1.2.1. Lack of therapeutic BCG vaccine
5.1.3. Opportunities
5.1.3.1. Untapped market in developing and underdeveloped countries
5.1.3.2. Growing initiatives by United Nations (UN) for TB preventions
5.1.4. Challenges
5.1.4.1. Side effects associated with BCG vaccine
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Therapeutic BCG Vaccine Market, by Type
6.1. Introduction
6.2. Immune BCG
6.3. Therapy BCG
7. Therapeutic BCG Vaccine Market, by Demographics
7.1. Introduction
7.2. Adults
7.3. Pediatrics
8. Therapeutic BCG Vaccine Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Hospitals
9. Americas Therapeutic BCG Vaccine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Therapeutic BCG Vaccine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Therapeutic BCG Vaccine Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AJ Vaccines A/S
13.1.2. Bharat Biotech Ltd.
13.1.3. Biomed-Lublin S.A.
13.1.4. China National Biotec Group Company Limited
13.1.5. Green Signal Bio Pharma Private Limited
13.1.6. InterVax Ltd.
13.1.7. Japan BCG Laboratory
13.1.8. Merck & Co., Inc.
13.1.9. Sanofi S.A.
13.1.10. Serum Institute of India Pvt. Ltd.
13.1.11. Statens Serum Institut
13.1.12. Taj Pharmaceuticals Limited
13.1.13. Torlak Institute of Virology
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. THERAPEUTIC BCG VACCINE MARKET RESEARCH PROCESS
FIGURE 2. THERAPEUTIC BCG VACCINE MARKET SIZE, 2023 VS 2030
FIGURE 3. THERAPEUTIC BCG VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. THERAPEUTIC BCG VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. THERAPEUTIC BCG VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. THERAPEUTIC BCG VACCINE MARKET DYNAMICS
FIGURE 7. THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2030 (%)
FIGURE 10. THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. THERAPEUTIC BCG VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. THERAPEUTIC BCG VACCINE MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. THERAPEUTIC BCG VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. THERAPEUTIC BCG VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. THERAPEUTIC BCG VACCINE MARKET SIZE, BY IMMUNE BCG, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. THERAPEUTIC BCG VACCINE MARKET SIZE, BY THERAPY BCG, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 9. THERAPEUTIC BCG VACCINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. THERAPEUTIC BCG VACCINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 12. THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 26. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 29. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. AUSTRALIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 43. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 46. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 52. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. SINGAPORE THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. TAIWAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 70. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. VIETNAM THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 80. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 83. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 86. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 89. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 92. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 98. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 107. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 110. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 113. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 125. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 134. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. THERAPEUTIC BCG VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 142. THERAPEUTIC BCG VACCINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 143. THERAPEUTIC BCG VACCINE MARKET LICENSE & PRICING

Companies Mentioned

  • AJ Vaccines A/S
  • Bharat Biotech Ltd.
  • Biomed-Lublin S.A.
  • China National Biotec Group Company Limited
  • Green Signal Bio Pharma Private Limited
  • InterVax Ltd.
  • Japan BCG Laboratory
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Statens Serum Institut
  • Taj Pharmaceuticals Limited
  • Torlak Institute of Virology

Methodology

Loading
LOADING...